Implantable technology for the treatment of high blood pressure

Startup

SOBRE CVRX

      
CVRx® is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is supported by an outstanding board of directors and a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure.

CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure. This new device called Barostim neo™  is designed to trigger the body’s own natural blood flow regulation system to treat high blood pressure and heart failure. CVRx has a strong intellectual property foundation, which will protect this unique technology.

Barostim neo is CE marked in Europe for the treatment of hypertension patients.   It is also CE marked in Europe for the treatment of heart failure. This product is currently under clinical evaluation in the United States and Canada for the treatment of high blood pressure and heart failure.
    
Organization founded in United States.

SECTORES - INDUSTRIA

UBICACIONES

COMPARTIR PERFIL

Este perfil tiene una gran apariencia, ¿quieres compatirlo con todos?
PRINCIPIANTE
AVANZADO
PROFESIONAL

NOTICIAS

Noticias añadidas recientemente sobre CVRx:
CVRx funding investment of 113M$

Esta web usa cookies para que podamos entender cómo se utiliza el sitio. Si sigues navegando asumiremos que te parece bien. Si quieres utilizar este sitio sin cookies o si quieres saber más, puedes hacerlo aquí .